SurModics to Present at Jefferies Healthcare Conference
May 27 2015 - 8:00AM
Business Wire
Webcast is Live on Wednesday, June 3, at 8:30
a.m. (ET)
SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industry, announced today that Gary Maharaj, president and chief
executive officer, and Andy LaFrence, vice president of finance and
chief financial officer, will make a presentation to the investment
community at the Jefferies Healthcare Conference in New York City
on Wednesday, June 3, 2015, at 8:30 a.m. ET
(7:30 a.m. CT).
A live audio webcast of the presentation will be available by
going to the investor relations portion of the Company’s website at
www.surmodics.com and clicking on the webcast icon. In addition,
the audio presentation will be archived on the Company’s website
for 90 days following the meeting.
About SurModics, Inc.
SurModics partners with the world's leading and emerging medical
device, diagnostic and life sciences companies to develop and
commercialize innovative products designed to improve lives by
enabling the detection and treatment of disease. The company’s core
offerings include surface modification coating technologies that
impart lubricity, prohealing and biocompatibility characteristics
and components for in vitro diagnostic test kits and microarrays.
SurModics’ strategy is to build on the product and technical
leadership within these fields, and expand the core offerings to
generate opportunities for longer term sustained growth. SurModics
is headquartered in Eden Prairie, Minnesota. For more information
about the Company, visit www.surmodics.com. The content of
SurModics’ website is not part of this press release or part of any
filings that the Company makes with the SEC.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150527005381/en/
SurModics, Inc.Andy LaFrence, 952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Apr 2023 to Apr 2024